Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tongwei Liu

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Oncology|June 27, 2025
Diagnostic value of exosome non-coding RNAs as non-invasive biomarkers in gastric cancer: a meta-analysisQiumiao Xu, Qinghong Yan, Zhijiang Dai, et al.
Oncology Letters|March 15, 2019
MicroRNA-218 inhibits the cell proliferation and migration in clear cell renal cell carcinoma through targeting cancerous inhibitor of protein phosphatase 2ARuojing Wei, Xiongjun Ye, Yawei Zhao, et al.
Oncology Letters|March 20, 2025
Safety and efficacy outcomes of delta‑like ligand 3 inhibitors for the treatment of solid tumors: A systematic review and single‑arm meta‑analysisYaxu Su, Xinyu Lu, Tongwei Liu, et al.
Frontiers in Oncology|January 2, 2026
Global research trends in signaling pathways of spasmolytic polypeptide-expressing metaplasia pathogenesis: a bibliometric analysisQiumiao Xu, Zhijiang Dai, Chengjin Peng, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Oncology|June 27, 2025
Diagnostic value of exosome non-coding RNAs as non-invasive biomarkers in gastric cancer: a meta-analysisQiumiao Xu, Qinghong Yan, Zhijiang Dai, et al.
Oncology Letters|March 15, 2019
MicroRNA-218 inhibits the cell proliferation and migration in clear cell renal cell carcinoma through targeting cancerous inhibitor of protein phosphatase 2ARuojing Wei, Xiongjun Ye, Yawei Zhao, et al.
Oncology Letters|March 20, 2025
Safety and efficacy outcomes of delta‑like ligand 3 inhibitors for the treatment of solid tumors: A systematic review and single‑arm meta‑analysisYaxu Su, Xinyu Lu, Tongwei Liu, et al.
Frontiers in Oncology|January 2, 2026
Global research trends in signaling pathways of spasmolytic polypeptide-expressing metaplasia pathogenesis: a bibliometric analysisQiumiao Xu, Zhijiang Dai, Chengjin Peng, et al.
Pageof 2